Ramp Metals (OTCQB:RMPMF) reported new drill results from its Rottenstone SW property, highlighted by drillhole Rush-019, which intersected 4.0 m grading 4.84% CuEq within 28.23 m averaging 0.86% CuEq, and additional 1.0 m of 1.90% CuEq near surface. Holes Rush-017 and Rush-018 also returned notable Cu-Zn-Ag intercepts, including 3.35 m at 4.40% CuEq and 22.5 m at 0.93% CuEq.
The company confirmed copper-zinc-silver mineralization in a second “Deep Zone” about 70 m west of the main trend, with Rush-014 intersecting 2.7 m at 2.76% CuEq and Rush-016 cutting 0.6 m at 7.77% CuEq. The Rush mineralized footprint now has a confirmed strike length of roughly 250 m and remains open along strike and at depth. All 2026 Rush holes have been reported, while assays for Runway, Redridge, Ranger and other targets are still pending.
Ramp Metals (OTCQB:RMPMF) reported new volcanogenic massive sulphide (VMS) drill results from the Rottenstone SW property in Saskatchewan.
Key intercepts include Rush-015 with 7.4m of 1.01% Cu, 7.07% Zn and 10.11 g/t Ag, and Rush-012 with 25.9m of 0.72% Cu and 1.71% Zn. The 2026 winter/spring program drilled 16 holes totaling 3,817.06m across six targets, and the company secured $150,000 in TMEI reimbursement approval.
Ramp Metals (OTC: RMPMF) reported a 21m intercept from Rush-011 grading 0.80% Cu, 17.01 g/t Ag, 0.09 g/t Au, 0.73% Zn, 0.23% Pb (50.5–71.5m), including higher-grade 3m and 3.5m subintervals. The hole extends Rush-010 mineralization at depth and confirms VMS-style mineralization across the 1,100m main Rush anomaly. Rush-012 assays remain pending; a new deeper zone west of known mineralization was identified and the program continues.
Ramp Metals (OTC: RMPMF) completed nine drill holes (2,199 m) at the 1,100 m Rush anomaly on Rottenstone SW, with all holes intersecting VMS-style mineralization including disseminated, semi-massive and massive sulphides.
The program discovered a new, deeper zone ~70 m west of the known trend. Four shipments of core were sent to Bureau Veritas for analysis; assays are pending. Company also began OTC quoting under RMPMF and is pursuing OTCID and DTC eligibility.